Screener
Generate Biomedicines, Inc. GENB Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $140.35M— | $135.36M-12.3% | $160.58M-27.2% | $121.65M— | $154.27M— | ||
| $263.86M— | $322.06M— | $356.07M— | $99.85M— | —— | ||
| $414.64M— | $470.25M— | $535.39M— | $234.37M— | —— | ||
| $38.65M— | $27.31M— | $27.84M— | $29.15M— | —— | ||
| $515.89M— | $561.69M— | $625.74M— | $330.18M— | —— | ||
| $7.89M— | $5.65M— | $7.62M+1,376% | $3.84M— | —— | ||
| $0— | $0— | —— | $4.51M— | —— | ||
| $12.5M— | $3.74M— | —— | $4.31M— | —— | ||
| $82.72M— | $56.64M— | $58.39M— | $82.2M— | —— | ||
| $134.73M— | $105.65M— | $110.94M— | $141.55M— | —— | ||
| $129K— | $128K— | —— | $33K— | —— | ||
| -$892.65M— | -$804.99M— | -$737.74M— | -$676.29M— | —— | ||
| $381.16M— | $456.05M+188% | $514.8M+209% | -$615.97M-41.8% | -$517.85M— | ||
| $515.89M— | $561.69M— | $625.74M— | $330.18M— | —— |
FAQ
- What are Generate Biomedicines, Inc.'s total assets?
- Generate Biomedicines, Inc. (GENB) holds $515.9M in total assets.
- How much debt does Generate Biomedicines, Inc. have?
- Generate Biomedicines, Inc. carries $75.3M in total debt against $381.2M of shareholders' equity, a debt-to-equity ratio of 0.20.
- How much cash does Generate Biomedicines, Inc. have?
- Generate Biomedicines, Inc. holds $140.4M in cash and equivalents.
- Can Generate Biomedicines, Inc. cover its short-term obligations?
- Its current ratio is 5.01 — current assets exceed current liabilities.
- Where does Generate Biomedicines, Inc.'s balance sheet data come from?
- Every line is extracted from Generate Biomedicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.